HomeNDC LookupRxCUI directory › RxCUI 310049

Echothiophate iodide 1.25 MG/ML Ophthalmic Solution — RxCUI 310049

RxNorm drug concept · Semantic clinical drug
RxCUI 310049 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310049
Official nameEchothiophate iodide 1.25 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asechothiophate iodide 0.125 % Ophthalmic Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)56 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Echothiophate iodide 1.25 MG/ML Ophthalmic Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Echothiophate iodide 1.25 MG/ML Ophthalmic Solution RxCUI 310049

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ecothiopate 89778
    • Echothiophate iodide 3740
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phospholine Iodide 204232
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ecothiopate Ophthalmic Solution 379134
    • Echothiophate iodide Ophthalmic Solution 2648843
    • Ecothiopate Ophthalmic Product 1162030
    • Echothiophate iodide Ophthalmic Product 2662143
    • Ecothiopate Ophthalmic Solution [Phospholine Iodide] 632266
    • Echothiophate iodide Ophthalmic Solution [Phospholine Iodide] 2656928
    • Phospholine Iodide Ophthalmic Product 1180641
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Echothiophate iodide 1.25 MG/ML SCDC · 331874
  • Ecothiopate Ophthalmic Solution SCDF · 379134
  • Echothiophate iodide Ophthalmic Solution SCDFP · 2648843
  • Ecothiopate Ophthalmic Product SCDG · 1162030
  • Echothiophate iodide Ophthalmic Product SCDGP · 2662143

Brand-Name Concepts

  • Echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] SBD · 205739
  • Echothiophate iodide 1.25 MG/ML [Phospholine Iodide] SBDC · 566627
  • Ecothiopate Ophthalmic Solution [Phospholine Iodide] SBDF · 632266
  • Echothiophate iodide Ophthalmic Solution [Phospholine Iodide] SBDFP · 2656928
  • Phospholine Iodide Ophthalmic Product SBDG · 1180641
  • Phospholine Iodide BN · 204232

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 310049 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
48102-0053-05 1 KIT in 1 CARTON (48102-053-05) * 6.25 mL in 1 BOTTLE (48... Phospholine Iodide Fera Pharmaceuticals, LLC 2022-06-01
Observed labelers: Fera Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.